Meperidine (Demerol) Market
Dolantin is synthetically called as ethyl 1-methyl-4-phenylisonipecotate hydrochloride. Dolantin is a part of a group of medicines called as anodyne palliative and is same as heroin. Dolantin is utilized for the therapy of average to highest agony. Anyhow, because of the less time of functioning, power, and mephitic of dolantin comparatively to other narcotic anodyne, the choice for dolantin amidst doctors has decreased in the present days.
The overall dolantin merchandise is estimated to be evaluated at US$ 480.4 million in 2021 and is anticipated to show a CAGR of 1.5% in the predicted duration (2021-2028).
Increasing count of clinical methods is anticipated to propel the merchandise development in the predicted duration.
๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐๐ง๐ ๐๐๐ญ ๐ ๐ฅ๐๐ญ ๐๐๐ ๐๐๐๐ ๐๐ ๐
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ ๐๐๐๐๐ฌ๐ฌ ๐ ๐ฎ๐ฅ๐ฅ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง @ https://www.coherentmarketinsights.com/promo/buynow/3816
The rising need for dolantin linked with its vast utilization as an anodyne in several clinical methods is anticipated to fuel the development of dolantin merchandise development in the predicted duration. For example, as per WHO 2021, it is stated that 143 million clinical methods are needed overall in the globe every year to rescue lives and obstruct malfunctioning. Moreover, as per the similar source, it is expected that in 2013, nearly 232 million operations were stated.
Rising cases of malignancy over the world is anticipated to fuel the overall dolantin merchandise development in the expected duration. For example, as per National Cancer Institute, it was approximated that 1,806,590 new incidences of malignancy would be examined in the U.S. and 606,520 individuals would pass away from the illness in 2020
Global Meperidine (Demerol) Marketโ Impact of COVID-19 Pandemic
Overall, as ofย 26 January 2022, there were 356,955,803ย assured incidencesย of corona virus, comprisingย 5,610,291ย mortalities, stated to WHO. As ofย 25 January 2022, a whole ofย 9,679,721,754ย immunizer dosagesย have been directed.
๐๐จ ๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐๐ญ๐๐ฌ๐ญ ๐๐จ๐ฏ๐ข๐๐๐ ๐๐ฆ๐ฉ๐๐๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ @ https://www.coherentmarketinsights.com/insight/request-sample/3816
Meperidine (Demerol) Market: Restraint
The main reason that hampers the development of the overall dolantin merchandise involve complications linked with medicaments and involvement of other anodyne medicaments. There are many things about different reactions, medicine interplay, and nor pethidine clioquinol which hinders the merchandise expansion.
Key Players
Main companies set up in the overall dolantin merchandise are Epic Pharma, Inc., Sanofi, Inc., Vintage Pharmaceuticals, Hikma Pharmaceuticals USA Inc., Inc., and Pfizer.
๐๐จ ๐๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ ๐๐ซ๐จ๐๐ก๐ฎ๐ซ๐ ๐๐๐ซ๐ @ https://www.coherentmarketinsights.com/insight/request-pdf/3816
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Form
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Regulatory Scenario
- Market Trends
- Key Developments
- Epidemiology
- PEST Analysis
- Brand Analysis
- PORTERโS Analysis
- Market Dynamics
- Global Meperidine (Demerol) Marketโ Impact of Coronavirus (COVID-19) Pandemic
- COVID 19 Epidemiology
- Impact on Supply and Demand
- Global Meperidine (Demerol) Market, By Form, 2017 โ 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 โ 2028
- Segment Trends
- Tablet
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 โ 2028, (US$ Mn)
- Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 โ 2028, (US$ Mn)
- Syrup
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 โ 2028, (US$ Mn)
- Introduction
- Global Meperidine (Demerol) Market, By ย Application,ย 2017 โ 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 โ 2028
- Segment Trends
- Anesthesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 โ 2028, (US$ Million)
- Cough Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 โ 2028, (US$ Million)
- Diarrhea Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 โ 2028, (US$ Million)
- Introduction
- Global Meperidine (Demerol) Market, By Distribution Channel, 2017 โ 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 โ 2028
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 โ 2028, (US$ Million)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 โ 2028, (US$ Million)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 โ 2028, (US$ Million)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/meperidine-market-3084
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837